Trending...
- For Labor Day: Check out a poem about Labor and Manufacturing called "It used to be Made in America" - 195
- California prioritized fighting organized retail theft, those results are paying off with 36,000 arrests and $293 million in stolen goods recovered - 104
- California and the Australian state of Queensland ink new partnership to accelerate climate resilience, agricultural technology, and innovation - 101
Eve Wellness located in SF offers the first FDA-approved ultrasound screening technology specifically designed for detecting cancer in dense breast tissue.
SAN FRANCISCO - Californer -- Eve Wellness, a San Francisco-based breast cancer screening clinic, is leading the charge in breast cancer screening by providing women the opportunity to get screened earlier, at any age, without a doctor referral, using their FDA-Approved GE ABUS ultrasound technology, powered by FDA-Approved AI (artificial intelligence), all without radiation. This comes on the heels of the FDA's new mandate, announced on March 9, 2023, requiring all mammography facilities to report breast density information and enhance communications with patients and providers.
The FDA's move is important because the risk of breast cancer is of real concern to many patients, said Dr. Harold Burstein, a medical oncologist at the Dana-Farber Cancer Institute in Boston and a professor at Harvard Medical School. "The identification of dense breast tissue can be a marker of slightly greater risk of getting breast cancer, and it may need additional breast imaging," said Burstein, who likened the challenge of reading mammograms to "looking through frosted glass."
More on The Californer
Breast density has been identified as a risk factor for breast cancer, and the FDA's new mandate aims to increase awareness and understanding of this risk. The mandate requires mammography facilities to provide patients with information about their breast density and the impact it can have on the accuracy of mammograms. Facilities are also required to communicate the findings with healthcare providers and provide recommendations for additional screening options, such as breast ultrasound.
"Today's action represents the agency's broader commitment to support innovation to prevent, detect and treat cancer," said Hilary Marston, M.D., M.P.H., FDA's Chief Medical Officer. "Since 1992, the FDA has worked to ensure patients have access to quality mammography. The impact of the Mammography Quality Standards Act on public health has been significant, including a steep decrease in the number of facilities that do not meet quality standards. This means that more women have access to consistent, quality mammography. We remain committed to advancing efforts to improve the health of women and strengthen the fight against breast cancer."
At Eve Wellness, breast ultrasound is the best option for women with dense breast tissue. Their GE ABUS ultrasound technology, powered by AI, can detect breast cancer at an earlier stage and without the use of radiation. With physician-read results back in less than 48 hours, Eve Wellness provides women with quick results, reducing anxiety and enabling early intervention.
More on The Californer
"Breast cancer claims the lives of nearly 43,000 women annually, and early detection is key to improving outcomes. Eve is on a mission to fill the void in breast cancer screening," said Brendan Foley, Co-Founder at Eve Wellness. "We are proud to lead the change in breast screening by providing women with access to the latest technology and empowering them to take control of their breast health."
Eve Wellness is committed to providing women with the best possible breast cancer screening options and is a game-changer in the fight against breast cancer. With the FDA's new mandate, women can feel more informed and empowered in their breast health decisions, and Eve Wellness is here to support them every step of the way.
For more information on Eve Wellness and their breast cancer screening services, visit their website at https://www.myevewellness.com/.
The FDA's move is important because the risk of breast cancer is of real concern to many patients, said Dr. Harold Burstein, a medical oncologist at the Dana-Farber Cancer Institute in Boston and a professor at Harvard Medical School. "The identification of dense breast tissue can be a marker of slightly greater risk of getting breast cancer, and it may need additional breast imaging," said Burstein, who likened the challenge of reading mammograms to "looking through frosted glass."
More on The Californer
- Franchise Operators Are Standardizing Compliance Across Every Location in 2026
- Impact & Influence March 2026: Joel Rodriguez Tirado - Why You're Still Waiting & The Power of Start
- New Comparison Helps Senior Travelers Weigh Overseas Adventure Travel Against Road Scholar
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Applications Now Open for the 2027 BrightEdge Entrepreneurs Program
Breast density has been identified as a risk factor for breast cancer, and the FDA's new mandate aims to increase awareness and understanding of this risk. The mandate requires mammography facilities to provide patients with information about their breast density and the impact it can have on the accuracy of mammograms. Facilities are also required to communicate the findings with healthcare providers and provide recommendations for additional screening options, such as breast ultrasound.
"Today's action represents the agency's broader commitment to support innovation to prevent, detect and treat cancer," said Hilary Marston, M.D., M.P.H., FDA's Chief Medical Officer. "Since 1992, the FDA has worked to ensure patients have access to quality mammography. The impact of the Mammography Quality Standards Act on public health has been significant, including a steep decrease in the number of facilities that do not meet quality standards. This means that more women have access to consistent, quality mammography. We remain committed to advancing efforts to improve the health of women and strengthen the fight against breast cancer."
At Eve Wellness, breast ultrasound is the best option for women with dense breast tissue. Their GE ABUS ultrasound technology, powered by AI, can detect breast cancer at an earlier stage and without the use of radiation. With physician-read results back in less than 48 hours, Eve Wellness provides women with quick results, reducing anxiety and enabling early intervention.
More on The Californer
- Mandeville Pests May Pose Serious Health Risks for Your Family
- xBxBio Advances Connected Cardiovascular Intelligence With Chapter 2 Release
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
"Breast cancer claims the lives of nearly 43,000 women annually, and early detection is key to improving outcomes. Eve is on a mission to fill the void in breast cancer screening," said Brendan Foley, Co-Founder at Eve Wellness. "We are proud to lead the change in breast screening by providing women with access to the latest technology and empowering them to take control of their breast health."
Eve Wellness is committed to providing women with the best possible breast cancer screening options and is a game-changer in the fight against breast cancer. With the FDA's new mandate, women can feel more informed and empowered in their breast health decisions, and Eve Wellness is here to support them every step of the way.
For more information on Eve Wellness and their breast cancer screening services, visit their website at https://www.myevewellness.com/.
Source: Eve Wellness, Inc.
0 Comments
Latest on The Californer
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
- TitleChain Foundation Issues Global Call to Build Public-Commons for Human-Controlled AI
- Lake Norman Philharmonic - Free Community Concert
- Los Angeles Massage Therapist Jesse Anoraj Places in Top Rankings at 2026 American Massage Championships
- City of Long Beach Issues Rain Advisory Due to Recent Showers
- Good Night, Oscar at North Coast Repertory Theatre
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- 99Websites Launches \$99 Done-for-You Website Service for Busy Professionals and Small Businesses
- Yalil Guerra's "Clave" to Receive World Premiere in New Symphonic Version at The Soraya
- solar bus stop led lighting for NCTD at 18 locations
- At 70, LA Woman Launches New E-Commerce Store One Year After Nerve Damage Left Her Unable to
- AI Visibility Campaign by 1stpage Reaches 800+ Citations Across Major AI Platforms in Four Months
- Apex Lane Logistics Surpasses 100-Truck Network as Southern California Freight Capacity Expands
- xBxBio Launches Public Repository for Connected Cardiovascular Intelligence
- Hard Drive Prices Up 40 to 90 Percent Since March: eRacks Publishes Its Own Six-Month Tracking
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Governor Gavin Newsom on California securing massive victory for democracy
- Della continues to shine with her new release, Now Breathe featuring Angel Sessions
- Citrus Heights-Based Antgava Focuses on Realistic Results in Upholstery Cleaning
- City of Long Beach to Hold Moment of Silence in Remembrance of 9/11 Terrorist Attacks
